Impairment of complex I may be associated with increased protein oxidation and nitration in the prefrontal cortex of patients with bipolar disorder. Therefore, complex I activity and mitochondrial dysfunction may be potential therapeutic targets for bipolar disorder.
No takes yet. Share an insight, caveat, or question.
Andreazza et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: